GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangzhou Kingmed Diagnostics Group Co Ltd (SHSE:603882) » Definitions » FFO per Share

Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) FFO per Share


View and export this data going back to 2017. Start your Free Trial

What is Guangzhou Kingmed Diagnostics Group Co FFO per Share?

FFO per Share only applies to REITs.


Guangzhou Kingmed Diagnostics Group Co Business Description

Traded in Other Exchanges
N/A
Address
International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2023, KingMed has 49 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
Executives
Hao Bi Xi Directors, senior managers
Wang Ling Lai Director
Yu Shi Hui senior management
Liang Yao Ming Director
Peng Yong Xiang Director